ELI LILLY & Co is 206.5x more valuable than Amneal Pharmaceuticals, Inc. by market capitalization ($1.067 T vs $5.17 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AMRX | LLY |
|---|---|---|
| Market cap | $5.17 B | $1.067 T |
| US-listed rank | #1379 | #11 |
| Revenue (latest FY) | $3.02B | $65.18B |
| Net income (latest FY) | $72.06M | $20.64B |
| Net margin | 2.4% | 31.7% |
| P/E (trailing FY) | 71.7 | 51.7 |
| SEC filings | 664 | 989 |
ELI LILLY & Co is 206.5x more valuable than Amneal Pharmaceuticals, Inc. by market capitalization ($1.067 T vs $5.17 B).
In their latest fiscal years, Amneal Pharmaceuticals, Inc. reported $3.02B in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Amneal Pharmaceuticals, Inc. and ELI LILLY & Co, or browse the full rankings.